These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4984039)

  • 1. Phenmetrazine vs. phenmetrazine with amobarbital for weight reduction: a double-blind study.
    Hadler AJ
    Curr Ther Res Clin Exp; 1969 Dec; 11(12):750-4. PubMed ID: 4984039
    [No Abstract]   [Full Text] [Related]  

  • 2. Weight reduction with phenmetrazine: a double-blind study.
    Hadler AJ
    Curr Ther Res Clin Exp; 1967 Sep; 9(9):462-7. PubMed ID: 4963979
    [No Abstract]   [Full Text] [Related]  

  • 3. Weight reduction with phenmetrazine and chlorphentermine a double-blind study.
    Hadler AJ
    Curr Ther Res Clin Exp; 1967 Nov; 9(11):563-9. PubMed ID: 4965505
    [No Abstract]   [Full Text] [Related]  

  • 4. The effectiveness of phenmetrazine in obesity.
    Jenner EB
    N Z Med J; 1968 Jan; 67(426):147-9. PubMed ID: 4867885
    [No Abstract]   [Full Text] [Related]  

  • 5. Weight reduction with chlorphenetermine and phenmetrazine in obese psychiatric patients during chlorpromazine therapy.
    Sletten IW; Ognjanov V; Menendez S; Sundland D; el-Toumi A
    Curr Ther Res Clin Exp; 1967 Nov; 9(11):570-5. PubMed ID: 4965506
    [No Abstract]   [Full Text] [Related]  

  • 6. Obesity: phenmetrazine effect without dietary restriction.
    Huston JR
    Ohio State Med J; 1966 Aug; 62(8):805-7. PubMed ID: 5329662
    [No Abstract]   [Full Text] [Related]  

  • 7. Chlorphentermine and phenmetrazine compared: weight reduction, side effects and psychological change.
    Sletten IW; Sundland D; Pichardo J; Viamontes G
    Mo Med; 1967 Nov; 64(11):927-9. PubMed ID: 6056101
    [No Abstract]   [Full Text] [Related]  

  • 8. A clinical trial of an appetite suppressant in refractory obesity (with a note on assessment of weight loss).
    Peaston MJ
    Br J Clin Pract; 1965 Sep; 19(9):503-6. PubMed ID: 5318222
    [No Abstract]   [Full Text] [Related]  

  • 9. Reduction of anxiety in the coronary-care unit. A controlled double-blind comparison of chlordiazepoxide and amobarbital.
    Hackett TP; Cassem NH
    Curr Ther Res Clin Exp; 1972 Oct; 14(10):649-56. PubMed ID: 4628807
    [No Abstract]   [Full Text] [Related]  

  • 10. ["Free" and "bound" plasmatic insulin activity in obese patients treated with phenmetrazine].
    Dascălu R; Gozariu L; Florescu O; Rosan L; Vişinescu I
    Stud Cercet Endocrinol; 1965; 16(3):279-84. PubMed ID: 5850641
    [No Abstract]   [Full Text] [Related]  

  • 11. [Controlled clinical trials of a new appetite-inhibiting drug].
    Bani G; Barba C; Ricci G
    Clin Ter; 1968 Oct; 47(2):161-74. PubMed ID: 5702726
    [No Abstract]   [Full Text] [Related]  

  • 12. Weight control in obese diabetics. A comparative trial of Filon and phenmetrazine.
    Buckle RM; Silverstone JT
    Br J Clin Pract; 1966 Jul; 20(7):363-5. PubMed ID: 5940969
    [No Abstract]   [Full Text] [Related]  

  • 13. A double-blind study of heteronium bromide and amobarbital in the management of gastrointestinal conditions associated with anxiety.
    Kasich AM
    Curr Ther Res Clin Exp; 1968 Oct; 10(10):508-13. PubMed ID: 4971465
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of Cafilon in the treatment of obesity (author's transl)].
    Honzák R; Rath R; Vondra K
    Cesk Gastroenterol Vyz; 1976 Apr; 30(3):155-61. PubMed ID: 1277334
    [No Abstract]   [Full Text] [Related]  

  • 15. [Changes in blood lipids in patients treated with reducing diets. Use of delayed-action phenmetrazine].
    Castillo Rosell S; Serrano Maass PA; Bisteni A; Calcáneo F
    Arch Inst Cardiol Mex; 1966; 36(4):454-63. PubMed ID: 5917992
    [No Abstract]   [Full Text] [Related]  

  • 16. [Psychoses induced by phenmetrazine].
    Negulici-Baliff E; Christodorescu D; Gheorghiu D
    Neurol Psihiatr Neurochir; 1969; 14(4):371-6. PubMed ID: 5356063
    [No Abstract]   [Full Text] [Related]  

  • 17. Pondex, a hydantoin derivative, in the management of obesity.
    Krese A; Kiselá J
    Ther Hung; 1968; 16(2):89-90. PubMed ID: 5666420
    [No Abstract]   [Full Text] [Related]  

  • 18. Repeated episodes of phenmetrazine psychosis.
    Ananth JV
    Can Med Assoc J; 1971 Dec; 105(12):1280-1. PubMed ID: 5150329
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of weight losses with three reducing regimens--diet therapy, phenmetrazine, and an amphetamine combination (obetrol).
    Berman MI; Anderson IR
    J Am Geriatr Soc; 1966 Jun; 14(6):623-30. PubMed ID: 4379966
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical evaluation of the activity oof 2 new anorectics].
    Rinetti M; Barbaresi F; Colombi L
    Schweiz Rundsch Med Prax; 1970 Apr; 59(17):633-7. PubMed ID: 4928198
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.